Dr. David Clunie[email protected]PACS/VNAImaging experts mull over color challengesColor images are technically difficult to deal with, creating a thorny issue that's growing as PACS broadens from radiology and cardiology to include other specialties that use color-heavy images. Medical informatics expert Dr. David Clunie discusses a recent meeting designed to provide a framework for handling color.May 27, 2013BreastBreast tomosynthesis challenges digital imaging infrastructureWhile the advent of digital breast tomosynthesis (DBT) in the U.S. has added an exciting weapon to the breast imaging armamentarium, these new capabilities have also led to significant image management challenges. DBT adopters need to be aware of and plan for issues such as large file sizes and proprietary file formats.March 20, 2013Page 1 of 1Top StoriesCTCT muscle metrics could help screen for sarcopeniaAbdominal CT muscle metrics taken from imaging of healthy young people show promise for opportunistic sarcopenia screening.Womens ImagingCancer incidence on rise in younger people, womenAssociationsFinancial shock waves strike close to radiology researchersMRICNN techniques outperform conventional DL for Alzheimer's diagnosisWomens ImagingAbout half of women undecided on AI's use in breast imaging
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
